Product Details for ANDA 076211
BENAZEPRIL HYDROCHLORIDE (BENAZEPRIL HYDROCHLORIDE)
5MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
20MG
Marketing Status: Prescription
40MG
Marketing Status: Prescription
5MG
Marketing Status: Prescription
Active Ingredient: BENAZEPRIL HYDROCHLORIDE
Proprietary Name: BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076211
Product Number: 001
Approval Date: Feb 11, 2004
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
BENAZEPRIL HYDROCHLORIDE (BENAZEPRIL HYDROCHLORIDE)
Proprietary Name: BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076211
Product Number: 001
Approval Date: Feb 11, 2004
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
10MG
Marketing Status: Prescription
Active Ingredient: BENAZEPRIL HYDROCHLORIDE
Proprietary Name: BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076211
Product Number: 002
Approval Date: Feb 11, 2004
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
BENAZEPRIL HYDROCHLORIDE (BENAZEPRIL HYDROCHLORIDE)
Proprietary Name: BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076211
Product Number: 002
Approval Date: Feb 11, 2004
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
20MG
Marketing Status: Prescription
Active Ingredient: BENAZEPRIL HYDROCHLORIDE
Proprietary Name: BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076211
Product Number: 003
Approval Date: Feb 11, 2004
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
BENAZEPRIL HYDROCHLORIDE (BENAZEPRIL HYDROCHLORIDE)
Proprietary Name: BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076211
Product Number: 003
Approval Date: Feb 11, 2004
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
40MG
Marketing Status: Prescription
Active Ingredient: BENAZEPRIL HYDROCHLORIDE
Proprietary Name: BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076211
Product Number: 004
Approval Date: Feb 11, 2004
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: BENAZEPRIL HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076211
Product Number: 004
Approval Date: Feb 11, 2004
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information